Comments
Actelion sees return to growth in 2014
08.05.2012. | ZURICH (Reuters) - Europe's leading biotech company Actelion is focusing its research and development on two areas of specialism and accelerating cost cuts as it set its future strategy on Tuesday after successful results from an important drug trial....
